Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia
Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of...
Gespeichert in:
Veröffentlicht in: | Obstetric anesthesia digest 1990-10, Vol.10 (3), p.131-131 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 131 |
---|---|
container_issue | 3 |
container_start_page | 131 |
container_title | Obstetric anesthesia digest |
container_volume | 10 |
creator | Dommisse, J |
description | Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled. |
doi_str_mv | 10.1097/00132582-199010000-00012 |
format | Article |
fullrecord | <record><control><sourceid>wolterskluwer_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00132582_199010000_00012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00132582-199010000-00012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c942-edbac2f509f937f20d6af61bd718769f6fd9ef6bd5d02934e351f0ff2c852b8f3</originalsourceid><addsrcrecordid>eNp1kM1OwzAQhC0EEqXwDn6BwNqunfiIqhaQikBqD9wsJ95tAvmp4lQVb09KgRsjrUaj3dnDxxgXcCvApncAQkmdyURYCwJGJeMIecYmQiuTaGX1OZuATHVijH67ZFcxvgNIEDabsOVrie3n0FUtX3eh2jfct4E_-22L8ZjW-3pX-gH5eDCUOG5av8UG24F3xBdF7ZtdrPw1uyBfR7z58SnbLBeb-WOyenl4mt-vksLOZIIh94UkDZasSklCMJ6MyEMqstRYMhQsksmDDiCtmqHSgoBIFpmWeUZqyrLT26LvYuyR3K6vGt9_OgHuiMP94nB_ONw3jrE6O1UPXT1gHz_q_QF7V6Kvh9L9R1F9Ad8wYwU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</title><source>Journals@Ovid Complete</source><creator>Dommisse, J</creator><creatorcontrib>Dommisse, J</creatorcontrib><description>Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.</description><identifier>ISSN: 0275-665X</identifier><identifier>EISSN: 1536-5395</identifier><identifier>DOI: 10.1097/00132582-199010000-00012</identifier><language>eng</language><publisher>Williams & Wilkins</publisher><ispartof>Obstetric anesthesia digest, 1990-10, Vol.10 (3), p.131-131</ispartof><rights>Williams & Wilkins 1990. All Rights Reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Dommisse, J</creatorcontrib><title>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</title><title>Obstetric anesthesia digest</title><description>Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.</description><issn>0275-665X</issn><issn>1536-5395</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNp1kM1OwzAQhC0EEqXwDn6BwNqunfiIqhaQikBqD9wsJ95tAvmp4lQVb09KgRsjrUaj3dnDxxgXcCvApncAQkmdyURYCwJGJeMIecYmQiuTaGX1OZuATHVijH67ZFcxvgNIEDabsOVrie3n0FUtX3eh2jfct4E_-22L8ZjW-3pX-gH5eDCUOG5av8UG24F3xBdF7ZtdrPw1uyBfR7z58SnbLBeb-WOyenl4mt-vksLOZIIh94UkDZasSklCMJ6MyEMqstRYMhQsksmDDiCtmqHSgoBIFpmWeUZqyrLT26LvYuyR3K6vGt9_OgHuiMP94nB_ONw3jrE6O1UPXT1gHz_q_QF7V6Kvh9L9R1F9Ad8wYwU</recordid><startdate>199010</startdate><enddate>199010</enddate><creator>Dommisse, J</creator><general>Williams & Wilkins</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199010</creationdate><title>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</title><author>Dommisse, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c942-edbac2f509f937f20d6af61bd718769f6fd9ef6bd5d02934e351f0ff2c852b8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Dommisse, J</creatorcontrib><collection>CrossRef</collection><jtitle>Obstetric anesthesia digest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dommisse, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</atitle><jtitle>Obstetric anesthesia digest</jtitle><date>1990-10</date><risdate>1990</risdate><volume>10</volume><issue>3</issue><spage>131</spage><epage>131</epage><pages>131-131</pages><issn>0275-665X</issn><eissn>1536-5395</eissn><abstract>Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.</abstract><pub>Williams & Wilkins</pub><doi>10.1097/00132582-199010000-00012</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0275-665X |
ispartof | Obstetric anesthesia digest, 1990-10, Vol.10 (3), p.131-131 |
issn | 0275-665X 1536-5395 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00132582_199010000_00012 |
source | Journals@Ovid Complete |
title | Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A39%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenytoin%20Sodium%20and%20Magnesium%20Sulphate%20in%20the%20Management%20of%20Eclampsia&rft.jtitle=Obstetric%20anesthesia%20digest&rft.au=Dommisse,%20J&rft.date=1990-10&rft.volume=10&rft.issue=3&rft.spage=131&rft.epage=131&rft.pages=131-131&rft.issn=0275-665X&rft.eissn=1536-5395&rft_id=info:doi/10.1097/00132582-199010000-00012&rft_dat=%3Cwolterskluwer_cross%3E00132582-199010000-00012%3C/wolterskluwer_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |